- Published on:
Havana, Oct 9 (Prensa Latina) Cuban scientists are developing a Phase III clinical trial of the drug Jusvinza, with immunomodulatory and anti-inflammatory effects, in patients with rheumatoid arthritis, Granma newspaper reported.
